SCHEMBL2995185

SCHEMBL2995185

Cc1ccc2c(c1)c(C(=O)C(=O)NC1CC1)c(Cl)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.41
FAAH O00519 1/20 0.40
LMNA P02545 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
SIGMAR1 Q99720 1/20 0.40
EPHX2 P34913 1/20 0.39
SOS1 Q07889 1/20 0.38
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
ALOX12 P18054 2/20 0.37
MDM2 Q00987 1/20 0.37
MEN1 O00255 1/20 0.37
ALPL P05186 1/20 0.37
ALPI P09923 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
TP53 P04637 1/20 0.37
F10 P00742 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995566 0.96 CNR2 (0.43) CNR2FAAHLMNASMN1; SMN2SIGMAR1
SCHEMBL2994617 0.96 CNR2 (0.41) CNR2FAAHLMNASMN1; SMN2SIGMAR1
SCHEMBL3007029 0.95 MAPT (0.44) CNR2FAAHLMNAMAPTALDH1A1
SCHEMBL2991069 0.93 SIGMAR1 (0.43) CNR2LMNASMN1; SMN2SIGMAR1EPHX2
SCHEMBL3008409 0.89 L3MBTL1 (0.43) CNR2LMNASMN1; SMN2SIGMAR1EPHX2
SCHEMBL3005711 0.89 LMNA (0.43) CNR2LMNASMN1; SMN2SIGMAR1EPHX2
SCHEMBL2995773 0.89 ALDH1A1 (0.46) CNR2LMNASMN1; SMN2SIGMAR1MAPT
SCHEMBL2998712 0.88 ALDH1A1 (0.47) CNR2LMNASMN1; SMN2SIGMAR1MAPT
SCHEMBL2993134 0.88 CNR2 (0.39) CNR2FAAHLMNASMN1; SMN2SIGMAR1
SCHEMBL3000642 0.88 FAAH (0.51) CNR2FAAHLMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
CN-102850324-A Indole compounds MICROBIA INC 2013-01-02 CN disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
EP-2049520-A2 INDOLE COMPOUNDS Ironwood Pharmaceuticals, Inc. (US) 2009-04-22 EP disclosed
WO-2008019357-A2 INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 CNR2 20/4885FAAH 109/4885LMNA 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.